Quantité totale PI	38
Rang # Quantité totale PI	37 444
Note d'activité PI	2,4/5.0    33
Rang # Activité PI	23 355
Classe Nice dominante	Services scientifiques, technolo...

Brevets Marques 16 2 5 2 12 0 1
Dernier brevet	2025 - Kdm1a inhibitors for the treatme...
Premier brevet	2014 - Kdm1a inhibitors for the treatme...
Dernière marque	2021 - I
Première marque	2014 - IMAGO BIOSCIENCES

Industrie (Classification de Nice)

Derniers inventions, produits et services 2023 Invention Methods for treatment of bone marrow failure and related conditions. in vivoex vivoex vivo with a... Invention Kdm1a inhibitors for the treatment of disease. Disclosed herein are new compounds and composition... Invention Methods for the enhancement of therapeutic effect of car-t cells. Provided herein is the use of L... Invention Pharmaceutical formulations for treating diseases mediated by kdm1a. Provided is a pharmaceutica... 2022 Invention Kdm1a inhibitors for the treatment of disease. The present disclosure relates to compounds and me... Invention Kdm1a inhibitors for the treatment of disease. Disclosed herein are new compounds and compositio... Invention Methods and processes for the preparation of kdm1a inhibitors. Provided in this disclosure are m... Invention Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasms.... 2021 P/S Pharmaceutical preparations for the treatment of genetic diseases that involve dysregulation of e... Invention Pharmaceutical formulations for treating diseases mediated by kdm1a. N-((RSHH-1,2,3-triazol-1-yl)... Invention Pharmaceutical formulations for treating diseases mediated by kdm1a. Provided is a pharmaceutical... P/S PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GENETIC DISEASES THAT INVOLVE DYSREGULATION OF E... Invention Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasms... 2017 Invention Compositions and methods for producing stereoisomerically pure aminocyclopropanes. The present d... Invention Methods and processes for the preparation of kdm1a inhibitors. Provided in this disclosure are me... Invention Compositions and methods for producing stereoisomerically pure aminocyclopropanes. The present di... 2016 Invention Kdm1a inhibitors for the treatment of disease. A compound of the formula:or a salt, po... 2014 P/S Pharmaceutical research and development Invention Kdm1a inhibitors for the treatment of disease. Disclosed herein are new compounds and compo...